Sabby Healthcare Volatility Master Fund, Ltd.
10% Owner

Sabby Healthcare Volatility Master Fund, Ltd. insider trades: Rosetta Genomics (ROSG) stock purchases

10% Owner, Rosetta Genomics Last trade Apr 26, 2018 11 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2014
3
Companies
last trade 2018

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Sabby Healthcare Volatility Master Fund, Ltd. reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Apr 26, 2018ROSG↑ Buy$2K
Mar 16, 2018ROSG↑ Buy$28K
Mar 15, 2018ROSG↑ Buy$50K
Mar 13, 2018ROSG↑ Buy$73K
Apr 15, 2014CLTX↑ Buy$101K
Apr 11, 2014CLTX↑ Buy$14K
Apr 8, 2014CLTX↑ Buy$383K
Apr 2, 2014CLTX↑ Buy$61K
Apr 1, 2014CLTX↑ Buy$48K
Mar 31, 2014CLTX↑ Buy$66K
Mar 27, 2014CLTX↑ Buy$108K
Mar 24, 2014CLTX↑ Buy$76K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Sabby Healthcare Volatility Master Fund, Ltd.'s insider trades

Sabby Healthcare Volatility Master Fund, Ltd. is a 10% owner of Rosetta Genomics (ROSG). Since Mar 24, 2014, it has reported 12 open-market purchases worth $1.0M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Its filings also include other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ROSG insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.